| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7381 |
| Human Intestinal Absorption | HIA+ | 0.9686 |
| Caco-2 Permeability | Caco2+ | 0.8475 |
| P-glycoprotein Substrate | Non-substrate | 0.7379 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9798 |
| Non-inhibitor | 0.9929 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9134 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8365 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8347 |
| CYP450 2D6 Substrate | Non-substrate | 0.9130 |
| CYP450 3A4 Substrate | Non-substrate | 0.7439 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8141 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5993 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9541 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8357 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7587 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7757 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9671 |
| Non-inhibitor | 0.9685 |
| AMES Toxicity | Non AMES toxic | 0.9387 |
| Carcinogens | Non-carcinogens | 0.8478 |
| Fish Toxicity | High FHMT | 0.9025 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7244 |
| Honey Bee Toxicity | High HBT | 0.7241 |
| Biodegradation | Not ready biodegradable | 0.7803 |
| Acute Oral Toxicity | III | 0.6781 |
| Carcinogenicity (Three-class) | Non-required | 0.5954 |